"10.1371_journal.pone.0104298","plos one","2014-08-06T00:00:00Z","Bal√°zs Szalay; √Åron Cseh; Gerg≈ë M√©sz√°ros; L√°szl√≥ Kov√°cs; Attila Balog; Barna V√°s√°rhelyi","Department of Laboratory Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary; First Department of Pediatrics, Faculty of Medicine, Semmelweis University, Budapest, Hungary; Department of Rheumatology, Faculty of Medicine, Albert Szent-Gy√∂rgyi Health Center, University of Szeged, Szeged, Hungary; MTA-SE, Pediatrics and Nephrology Research Group, Budapest, Hungary","Conceived and designed the experiments: BS AB BV. Performed the experiments: BS LK AB. Analyzed the data: BS √ÅC GM AB. Contributed reagents/materials/analysis tools: BS AB. Wrote the paper: BS AB BV. Designed the software and algorithm used in analysis: AC GM.","The authors confirm that their funding from commercial sources (Abbott Laboratories and Pfizer) does not alter their adherence to PLOS ONE policies on sharing data and materials. The drugs used for patients‚Äô treatment were prescribed by independent doctors, and were purchased and provided by assigned wholesalers in agreement with national contracts with the Hungarian National Health Fund, and reimbursed by the Hungarian National Health Fund. Participation in the study by the patients had no impact whatsoever on the therapeutic decisions made by the treating physicians.","2014","08","Bal√°zs Szalay","B√S",6,TRUE,3,3,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
